A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent - Wikidata - wikimedia - TriplyDB

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

http://www.wikidata.org/entity/Q57914607

about

Everolimus-eluting stents in interventional cardiology Clinical utility of platinum chromium bare-metal stents in coronary heart disease Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes Advances in stent technologies and their effect on clinical efficacy and safety The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial New-Generation Coronary Stents: Current Data and Future Directions.Comparison of zotarolimus- and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE all-comers trial.Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review.Uniform and accelerated degradation of pure iron patterned by Pt disc arrays.A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease.Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.Nickel-free stainless steel avoids neointima formation following coronary stent implantation.Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.Restenosis after PCI. Part 2: prevention and therapy.Everolimus-eluting stents: update on current clinical studies.Second generation drug-eluting stents: a review of the everolimus-eluting platform.Are we aware of stent fracture?Current application and bioavailability of drug-eluting stents.Coronary stent fracture: a recently appreciated phenomenon with clinical relevance.Drug-eluting stents: the past, present, and future.Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.Coronary Stent Materials and Coatings: A Technology and Performance Update.Drug-eluting stents to prevent stent thrombosis and restenosis.Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial.Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).Investigating the feasibility of using a grit blasting process to coat nitinol stents with hydroxyapatite.Randomized comparison of acute stent malapposition between platinum-chromium versus cobalt-chromium everolimus-eluting stents.Procedural effectiveness of a novel 1.20 mm diameter angioplasty catheter: clinical and angiographic outcomes.Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions.Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation: Insights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis.Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions."Procedural trauma risks longitudinal shortening of the Promus Element™ stent platform".Longitudinal compression of the platinum-chromium everolimus-eluting stent during coronary implantation: predisposing mechanical properties, incidence, and predictors in a large patient cohort.Occurrence and predictors of acute stent recoil-A comparison between the xience prime cobalt chromium stent and the promus premier platinum chromium stent.Comparison of clinical outcomes of coronary artery stent implantation in patients with end-stage chronic kidney disease including hemodialysis for three everolimus eluting (EES) stent designs: Bioresorbable polymer-EES, platinum chromium-EES, and co Optical frequency-domain imaging findings to predict good stent expansion after rotational atherectomy for severely calcified coronary lesions.Long-Term Results from the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Femoropopliteal Treatment: 3-Year Follow-up.

P2860

Q24630321-C11883D0-C2E7-4AAF-BBEF-43117A5CFE44 Q26783440-36388208-EAD5-40F6-8327-1A43D3885126 Q26798582-9D2E417B-60C9-4E2F-9FD4-5C256F27AE76 Q28972437-93D6BD0F-F685-4A85-81D0-F72732381499 Q30513934-BED3D510-30B0-4479-BF3D-6E2CAFB57B6E Q31164040-319154FA-B8B7-41AE-8D55-DEC8A50F4BDD Q35831446-CFB5013F-DDD5-4BCB-9C5F-33DEF31B0011 Q36705836-CAEF3DD2-7523-4ADE-A05A-48395828796E Q36754642-3F2793DD-E369-4718-9F4A-153FB6152178 Q36954581-E7AEE9C4-8AA3-43BC-AF78-6F8AE07AE499 Q37284036-FDD69D9F-CF65-45B5-A592-8DEC08DD6925 Q37399954-03B8F545-5FF8-4095-8B36-327794505585 Q37511128-9F25819E-7335-4EC1-930D-6E49B5085FAC Q37944416-7EE8A7B0-F707-4A47-923C-DB9D93A339FC Q38037072-1EC47C11-310D-42CA-881F-5BDC17E09F57 Q38127415-FD6312B6-3A84-4EB9-9849-6060417C210E Q38155103-CBD8C4E2-150F-44B3-B313-B15B24CB5FE4 Q38188578-9F59786B-C14C-4F03-BCA1-CCB40CBD9705 Q38203575-8BF6665F-D352-4343-8052-5BF2F1DE2FF4 Q38344198-A2F33B71-1982-43F8-9CD5-35A8EF18D9C1 Q38392409-A8B0F8CE-6E50-41AE-B70C-166E34D1B3C4 Q38542307-C9B7565E-60B8-4AF6-ABCD-DEEE12BE8EC5 Q38633332-A77D6F01-4983-41C4-A850-F3C5E95C6ED7 Q38764106-257005E8-5C09-440E-8243-2719439EBE3F Q38818354-47C555EC-256D-4B86-BA22-7692A4CA96DE Q39435685-5642D726-F9CD-474A-8FC8-C51584C2ECAD Q39852610-BB2969E0-FEED-4F0C-99FF-9EBA5D233584 Q43477596-037188B8-08D0-4EAA-9D2A-E9272577AAA2 Q43941133-450BA287-B520-440C-AB31-D65F7BCE15EC Q44745465-5408DCAA-5567-4E25-8877-5CA93C359657 Q45189284-28DF56FD-9E93-47FB-9C3A-71B399F8A309 Q45953456-F0D4AEB5-68F5-4943-9E66-CCB971BCD7D6 Q45979909-C576C055-D01F-4339-8C7E-0E2542297270 Q46405787-8638D6F0-09C0-49D9-9BD1-3963E3C0329F Q47253825-E412629A-FCA0-42D7-A7CC-15584A4AB0CC Q47771413-BFB98E3C-8217-4FC8-8BF4-7B0051AF54A6 Q48148766-967C6C99-43D8-4526-98B6-0E6864200D24 Q48252185-2BF63AF2-6193-4490-88BF-F145A8E59E94 Q48274572-871B6B5A-9B21-4F3D-84F9-C95DED56218D Q49835658-4EADE886-70FF-4146-BECA-2B64BBA7BBA1

P2860

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

http://www.wikidata.org/entity/Q57914607

description

article

@en

im April 2011 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у квітні 2011

@uk

name

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

@en

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

@nl

type

label

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

@en

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

@nl

prefLabel

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

@en

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

@nl

P1433

Q57914607-C1F3C1EF-C9DF-42A0-9CE6-BBE48EEF41E3

P1476

Q57914607-17D04C13-0142-48EC-829B-198DCB9845DF

P2093

Q57914607-0487BB0F-A34C-4ED2-954E-84ED62EBD309

Q57914607-18C5D344-4E3F-4D13-842B-0064FCC43AE9

Q57914607-3B701E1C-994A-4E9A-A9BF-BA2222AFF5E1

Q57914607-4B309575-E963-4C97-AFF8-BA2C57EA1F80

Q57914607-503121E8-FECF-44FC-93E6-AB4AAB3AF720

Q57914607-5081A083-2331-43F8-9538-A7AFB780F195

Q57914607-6C1F3E3A-8ABF-45F6-8607-AB043597F543

Q57914607-81074A56-923E-46D8-BEC8-1AF04986C5FA

Q57914607-C6B910E1-2E3C-4F45-AE00-40C049582AE8

Q57914607-CAED2107-26DA-473C-BD92-B97F0F3ED2DF

P304

Q57914607-DBB56589-33B0-41E7-AC58-62CF86C03706

P31

Q57914607-5A894A5C-08C4-40B3-8B0A-5FDE26C5B521

P356

Q57914607-6CE08937-2CA9-459C-990E-372A5C221B34

P407

Q57914607-AA09EAF3-7ECF-4F89-9EF8-49855257420D

P433

Q57914607-4F461800-F64B-4E82-AF8D-96B4D622254C

P478

Q57914607-12AFA5AC-F3F8-4BB8-8DF3-C0E4BEB125EC

P577

Q57914607-96C6FF2C-BE35-47D2-8F72-2DFF50EF3DDA

P698

Q57914607-74FBF49B-3DE8-4BD8-B41C-72AB10151DC9

P356

J.JACC.2011.02.016

P1433

Journal of the American College of Cardiology

P1476

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

@en

P2093

Bruno Farah

http://www.w3.org/2001/XMLSchema#string

Christophe L. Dubois

http://www.w3.org/2001/XMLSchema#string

Dominic J. Allocco

http://www.w3.org/2001/XMLSchema#string

Gregg W. Stone

http://www.w3.org/2001/XMLSchema#string

Ian T. Meredith

http://www.w3.org/2001/XMLSchema#string

Joseph Dens

http://www.w3.org/2001/XMLSchema#string

Keith D. Dawkins

http://www.w3.org/2001/XMLSchema#string

Nobuhisa Hagiwara

http://www.w3.org/2001/XMLSchema#string

Paul S. Teirstein

http://www.w3.org/2001/XMLSchema#string

Robert L. Feldman

http://www.w3.org/2001/XMLSchema#string

P304

1700-1708

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2011.02.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21470815

http://www.w3.org/2001/XMLSchema#string